Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myobloc for Acute Low Back Pain
NCT00384579Phase 4Terminated
- Sponsor
- United States Department of Defense
- Start
- Feb 2008
- Primary completion
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute low back pain comparing Myobloc with Placebo (2 arms). Primary endpoint: Significant improvement in lower back pain at 8 weeks. Started Feb 2008; status: terminated.
02
Drugs
botulinum toxin type b
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT00384579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384579.